Should ADHD or addiction be treated first in dual diagnosis?
When ADHD and addiction occur together, knowing which condition to treat first can be complex. According to NICE and NHS England, stabilising substance use should come first, but ADHD shouldn’t be ignored. Early assessment and integrated care are key to better long-term outcomes.
What the evidence shows
NICE guidance advises that ADHD should only be formally diagnosed and treated once substance use has stabilised, particularly when considering stimulant medication. This approach, set out in NICE NG87 and NICE NG58, reduces diagnostic error and improves medication safety. The Royal College of Psychiatrists (RCPsych) and the NHS England ADHD Taskforce (2025) echo this: treat substance misuse first but begin ADHD assessment as soon as the person is stable enough to engage.
Why sequencing matters
Treating ADHD too early can lead to safety risks, such as stimulant misuse, incomplete diagnosis, or relapse during active addiction. However, delaying ADHD care for too long also has consequences; untreated ADHD increases impulsivity, relapse risk, and poor engagement in addiction recovery. RCPsych and NICE both recommend a phased or parallel model: stabilise substance use, start assessment early, and coordinate both treatments through shared care agreements. This allows ADHD symptoms to be addressed safely as recovery progresses.
How integrated care helps
Integrated or “dual diagnosis” pathways bring together addiction, mental health, and neurodevelopmental teams. Evidence from the NHS England Taskforce shows that shared-care models and digital coordination tools reduce delays, improve engagement, and lower relapse risk. Where medication is indicated, NICE and RCPsych recommend non-stimulant options such as atomoxetine in early recovery, or closely supervised stimulant use only once substance misuse is stable (RCPsych CR243, 2025).
Key takeaway
Addiction must be treated first, but ADHD should be recognised and assessed early, even during stabilisation. Integrated, person-centred care ensures both conditions are addressed safely and effectively. Private and NHS-aligned services such as ADHD Certify provide structured post-diagnostic support that complements NHS addiction and neurodevelopmental care.
Takeaway
Treating addiction first protects safety but assessing and managing ADHD as stability returns helps sustain recovery. Dual focus, not delay, delivers the best outcomes for people living with both ADHD and addiction.

